(Q40628180)

22 September 2017

title

Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein (English)

1 reference

22 September 2017

0 references

1 reference

M Djavani

1

1 reference

22 September 2017

C Yin

2

1 reference

22 September 2017

L Xia

3

1 reference

22 September 2017

I S Lukashevich

4

1 reference

22 September 2017

C D Pauza

5

1 reference

22 September 2017

M S Salvato

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

22 September 2017

1 reference

22 September 2017

volume

18

1 reference

22 September 2017

issue

15

1 reference

22 September 2017

page(s)

1543-1554

1 reference

Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Murine infection with lymphocytic choriomeningitis virus following gastric inoculation.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Dissemination of lymphocytic choriomeningitis virus from the gastric mucosa requires G protein-coupled signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Recombinant avirulent salmonellae as oral vaccine carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Immunization of Macaca mulatta with aroA attenuated Salmonella typhimurium expressing the SIVp27 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Anti-IFN-gamma-treated mice--a model for testing safety of live Salmonella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Recombinant, attenuated Salmonella typhimurium stimulate lymphoproliferative responses to SIV capsid antigen in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Clinical virology of Lassa fever in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Lassa fever: implications of T-cell immunity for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Vaccinia virus: a tool for research and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Applications of pox virus vectors to vaccination: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Positive selection for loss of tetracycline resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Trans-complementation-dependent replication of a low molecular weight origin fragment from plasmid R6K

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

High efficiency transformation of E. coli by high voltage electroporation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Delivery of epitopes by the Salmonella type III secretion system for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

DNA vaccination against persistent viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900439-9

7 January 2021

10.1016/S0264-410X(99)00439-9

Identifiers

DOI

1 reference

22 September 2017

1 reference